Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model
2021 ◽
Vol 394
(11)
◽
pp. 2309-2322
2011 ◽
Vol 102
(11)
◽
pp. 2029-2037
◽
2004 ◽
Vol 1030
(1)
◽
pp. 208-218
◽